<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>mobihealthnews&#187; Novartis</title>
	<atom:link href="http://mobihealthnews.com/tag/novartis/feed/" rel="self" type="application/rss+xml" />
	<link>http://mobihealthnews.com</link>
	<description>mobihealthnews - the daily mHealth industry monitor.  Subscribe for our free weekly e-newsletter!</description>
	<lastBuildDate>Fri, 10 Feb 2012 19:24:35 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Proteus receives patent for ingestible sensor</title>
		<link>http://mobihealthnews.com/11923/proteus-receives-patent-for-ingestible-sensor/</link>
		<comments>http://mobihealthnews.com/11923/proteus-receives-patent-for-ingestible-sensor/#comments</comments>
		<pubDate>Fri, 15 Jul 2011 00:42:49 +0000</pubDate>
		<dc:creator>Brian Dolan</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Avery Dennison]]></category>
		<category><![CDATA[intelligent medicine]]></category>
		<category><![CDATA[Kaiser Permanente]]></category>
		<category><![CDATA[Medtronic]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[ON Semiconductor]]></category>
		<category><![CDATA[Proteus Biomedical]]></category>

		<guid isPermaLink="false">http://mobihealthnews.com/?p=11923</guid>
		<description><![CDATA[Proteus Biomedical announced today that it has received a patent for its ingestible biomedical sensor &#8212; what the company has referred to as &#8220;intelligent medicine&#8221; in the past and what many have referred to as a &#8220;chip in a pill.&#8221; The patent announcement also included new information about Proteus&#8217; partners: While the Novartis relationship had [...]]]></description>
		<wfw:commentRss>http://mobihealthnews.com/11923/proteus-receives-patent-for-ingestible-sensor/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
		<item>
		<title>10 iPhone apps created by pharma companies</title>
		<link>http://mobihealthnews.com/9989/10-iphone-apps-created-by-pharma-companies/</link>
		<comments>http://mobihealthnews.com/9989/10-iphone-apps-created-by-pharma-companies/#comments</comments>
		<pubDate>Thu, 20 Jan 2011 00:02:07 +0000</pubDate>
		<dc:creator>Brian Dolan</dc:creator>
				<category><![CDATA[Slideshow]]></category>
		<category><![CDATA[GlaxoSmithKline]]></category>
		<category><![CDATA[iPhone medical apps]]></category>
		<category><![CDATA[Johnson and Johnson]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[pharma iPhone apps]]></category>
		<category><![CDATA[Sanofi Aventis]]></category>

		<guid isPermaLink="false">http://mobihealthnews.com/?p=9989</guid>
		<description><![CDATA[We mentioned a report last week from the Digital Pharma Blog that Pfizer, Johnson &#38; Johnson and Merck had each removed apps from the Apple AppStore in recent months. While many others covering this story attributed the move to a potential rethinking on the value of apps, the Digital Pharma Blog attributes many of the [...]]]></description>
		<wfw:commentRss>http://mobihealthnews.com/9989/10-iphone-apps-created-by-pharma-companies/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
		<item>
		<title>Novartis seeks regulatory approval for Proteus</title>
		<link>http://mobihealthnews.com/9434/novartis-seeks-regulatory-approval-for-proteus/</link>
		<comments>http://mobihealthnews.com/9434/novartis-seeks-regulatory-approval-for-proteus/#comments</comments>
		<pubDate>Wed, 10 Nov 2010 17:01:30 +0000</pubDate>
		<dc:creator>Brian Dolan</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[FDA regulatory approval]]></category>
		<category><![CDATA[intelligent medicine]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[Proteus Biomedical]]></category>
		<category><![CDATA[Proteus Raisin System]]></category>
		<category><![CDATA[wireless health sensors]]></category>

		<guid isPermaLink="false">http://mobihealthnews.com/?p=9434</guid>
		<description><![CDATA[Within the next 18 months, Novartis plans to seek regulatory approval for Proteus Biomedical&#8217;s microchipped pills, which tracks medication adherence by time-stamping the patients ingestion of medications. Novartis global head of development Trevor Mundel told attendees at the recent Reuters Health Summit in New York that it will submit the smart pill system for regulatory [...]]]></description>
		<wfw:commentRss>http://mobihealthnews.com/9434/novartis-seeks-regulatory-approval-for-proteus/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>SMS reminders don&#8217;t work for birth control</title>
		<link>http://mobihealthnews.com/8694/sms-reminders-dont-work-for-birth-control/</link>
		<comments>http://mobihealthnews.com/8694/sms-reminders-dont-work-for-birth-control/#comments</comments>
		<pubDate>Tue, 24 Aug 2010 15:16:18 +0000</pubDate>
		<dc:creator>Brian Dolan</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[CareSpeak]]></category>
		<category><![CDATA[GlowCaps]]></category>
		<category><![CDATA[medication adherence]]></category>
		<category><![CDATA[Mt. Sinai Medical Center]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[Partners Health Care]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Proteus Biomedical]]></category>
		<category><![CDATA[SMS]]></category>
		<category><![CDATA[Vitality]]></category>

		<guid isPermaLink="false">http://mobihealthnews.com/?p=8694</guid>
		<description><![CDATA[That is, at least, according to a new study published in Obstetrics &#38; Gynecology: Daily text message reminders did not help the 82 women in the study become more adherent to their birth control pill regimen. Both the text-receiving participants and the control group missed about 5 pills per month. (Worth noting perhaps that, according [...]]]></description>
		<wfw:commentRss>http://mobihealthnews.com/8694/sms-reminders-dont-work-for-birth-control/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>NHS tests Proteus Biomedical&#8217;s smart pills</title>
		<link>http://mobihealthnews.com/8634/nhs-tests-proteus-biomedicals-smart-pills/</link>
		<comments>http://mobihealthnews.com/8634/nhs-tests-proteus-biomedicals-smart-pills/#comments</comments>
		<pubDate>Thu, 12 Aug 2010 21:28:52 +0000</pubDate>
		<dc:creator>Brian Dolan</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[heart failure wireless health]]></category>
		<category><![CDATA[medication adherence]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[Proteus Biomedical]]></category>
		<category><![CDATA[UK NHS mHealth]]></category>
		<category><![CDATA[wireless sensor monitoring]]></category>

		<guid isPermaLink="false">http://mobihealthnews.com/?p=8634</guid>
		<description><![CDATA[The United Kingdom&#8217;s National Health Service plans to begin piloting Proteus Biomedical&#8217;s &#8220;smart pills&#8221; this month to help curb health costs due to medication non-adherence among heart failure patients, according to a report in the Financial Times. The Royal Berkshire and Imperial College healthcare trusts are currently looking for 40 patients for the clinical trial, which [...]]]></description>
		<wfw:commentRss>http://mobihealthnews.com/8634/nhs-tests-proteus-biomedicals-smart-pills/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
		<item>
		<title>Shorts: Text4Baby; iPlato; iTriage</title>
		<link>http://mobihealthnews.com/7368/shorts-text4baby-iplato-itriage/</link>
		<comments>http://mobihealthnews.com/7368/shorts-text4baby-iplato-itriage/#comments</comments>
		<pubDate>Mon, 26 Apr 2010 14:47:41 +0000</pubDate>
		<dc:creator>Brian Dolan</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[anti-malaria]]></category>
		<category><![CDATA[Czech Republic]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[Google]]></category>
		<category><![CDATA[Healthagen]]></category>
		<category><![CDATA[IBM]]></category>
		<category><![CDATA[iPlato]]></category>
		<category><![CDATA[iTriage]]></category>
		<category><![CDATA[MTV]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[Telemundo]]></category>
		<category><![CDATA[Text4Baby]]></category>
		<category><![CDATA[Vodafone]]></category>

		<guid isPermaLink="false">http://mobihealthnews.com/?p=7368</guid>
		<description><![CDATA[Text4Baby update: Forty states are in the process of creating Text4Baby coalitions and encouraging nurses to talk up the program, according to a recent report in Time magazine. The report also notes that another major television channel, besides MTV, is also promoting the text message powered service: Telemundo. More
iPlato has a new customer, this time outside [...]]]></description>
		<wfw:commentRss>http://mobihealthnews.com/7368/shorts-text4baby-iplato-itriage/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA grants Proteus Biomedical 510(k) clearance</title>
		<link>http://mobihealthnews.com/7343/fda-grants-proteus-biomedical-510k-clearance/</link>
		<comments>http://mobihealthnews.com/7343/fda-grants-proteus-biomedical-510k-clearance/#comments</comments>
		<pubDate>Wed, 21 Apr 2010 17:45:10 +0000</pubDate>
		<dc:creator>Brian Dolan</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Metronic]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[ON Semiconductor]]></category>
		<category><![CDATA[Proteus Biomedical]]></category>
		<category><![CDATA[remote patient monitoring]]></category>
		<category><![CDATA[wireless remote patient monitoring]]></category>

		<guid isPermaLink="false">http://mobihealthnews.com/?p=7343</guid>
		<description><![CDATA[The FDA announced today that it has cleared Proteus Biomedical&#8217;s wireless, adhesive sensor technology Raisin, which can track and record a patient&#8217;s heart rate, physical activity, body position and other biometrics. Raisin then transmits the data via Bluetooth to a PC or mobile device. Proteus explains that the Raisin device is worn just like a [...]]]></description>
		<wfw:commentRss>http://mobihealthnews.com/7343/fda-grants-proteus-biomedical-510k-clearance/feed/</wfw:commentRss>
		<slash:comments>5</slash:comments>
		</item>
		<item>
		<title>Can technology address medication adherence?</title>
		<link>http://mobihealthnews.com/6197/can-technology-address-medication-adherence/</link>
		<comments>http://mobihealthnews.com/6197/can-technology-address-medication-adherence/#comments</comments>
		<pubDate>Thu, 21 Jan 2010 10:35:43 +0000</pubDate>
		<dc:creator>Brian Dolan</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[Medic8 Personal Caregiver]]></category>
		<category><![CDATA[medication adherence]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[Proteus Biomedical]]></category>
		<category><![CDATA[RememberItNow]]></category>

		<guid isPermaLink="false">http://mobihealthnews.com/?p=6197</guid>
		<description><![CDATA[It&#8217;s a widely known statistic that between one-third and one-half of patients in the U.S. do not take their medications as instructed, which leads to poorer health, more frequent hospitalization, a higher risk of death and up to $290 billion each year in increased medical costs. Stacked against that figure, Novartis&#8217; recent $24 million investment [...]]]></description>
		<wfw:commentRss>http://mobihealthnews.com/6197/can-technology-address-medication-adherence/feed/</wfw:commentRss>
		<slash:comments>12</slash:comments>
		</item>
		<item>
		<title>Analysis: Rationale and challenges to Novartis-Proteus</title>
		<link>http://mobihealthnews.com/6133/analysis-rationale-and-challenges-to-novartis-proteus/</link>
		<comments>http://mobihealthnews.com/6133/analysis-rationale-and-challenges-to-novartis-proteus/#comments</comments>
		<pubDate>Tue, 19 Jan 2010 13:23:18 +0000</pubDate>
		<dc:creator>Brian Dolan</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Alcon]]></category>
		<category><![CDATA[intelligent medicine]]></category>
		<category><![CDATA[medication adherence]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Proteus Biomedical]]></category>
		<category><![CDATA[venture capital]]></category>

		<guid isPermaLink="false">http://mobihealthnews.com/?p=6133</guid>
		<description><![CDATA[According to a report in the Economist, pharmaceuticals company Novartis&#8217; $24 million investment in intelligent medicine startup Proteus Biomedical may be just as important in the long run as Novartis&#8217; $50 billion takeover of eye-care firm, Alcon. Proteus Biomedical&#8217;s venture capital round actually brought in $25.4 million, which makes us wonder if the difference came [...]]]></description>
		<wfw:commentRss>http://mobihealthnews.com/6133/analysis-rationale-and-challenges-to-novartis-proteus/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Novartis invests $24M in Proteus Biomedical</title>
		<link>http://mobihealthnews.com/6013/novartis-invests-24m-in-proteus-biomedical/</link>
		<comments>http://mobihealthnews.com/6013/novartis-invests-24m-in-proteus-biomedical/#comments</comments>
		<pubDate>Tue, 12 Jan 2010 13:47:42 +0000</pubDate>
		<dc:creator>Brian Dolan</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[cardiovascular]]></category>
		<category><![CDATA[Diovan]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[organ transplantation]]></category>
		<category><![CDATA[pharmaceuticals]]></category>
		<category><![CDATA[Proteus Biomedical]]></category>
		<category><![CDATA[psychiatric]]></category>
		<category><![CDATA[tuberculosis]]></category>
		<category><![CDATA[venture capital]]></category>

		<guid isPermaLink="false">http://mobihealthnews.com/?p=6013</guid>
		<description><![CDATA[Pharmaceutical giant Novartis announced that would invest $24M in upfront cash and equity as part of an exclusive worldwide agreement for the pharma company to license Proteus Biomedical&#8217;s sensing technology for organ transplantation. (That must be the kind of exclusive deal Novartis had in mind when the two companies announced their collaboration on a pilot [...]]]></description>
		<wfw:commentRss>http://mobihealthnews.com/6013/novartis-invests-24m-in-proteus-biomedical/feed/</wfw:commentRss>
		<slash:comments>8</slash:comments>
		</item>
	</channel>
</rss>

<!-- Dynamic Page Served (once) in 4.597 seconds -->

